Pyxis Oncology (PYXS) Earnings Date & Reports

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYXS is expected to report earnings to fall 1.91% to -34 cents per share on August 19

Pyxis Oncology PYXS Stock Earnings Reports

Q2'25

Est.

$-0.34

Q1'25

Missed

by $0.02

Q4'24

Missed

by $1.00

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.05

The last earnings report on May 15 showed earnings per share of -34 cents, missing the estimate of -33 cents. With 458.63K shares outstanding, the current market capitalization sits at 76.51M.

View a ticker or compare two or three

Compare

PYXS